is imcivree a glp 1 Rhythm Pharmaceuticals' becomes the first FDA-approved treatment for acquired hypothalamic obesity. ㅤ Link in bio. ㅤ #longevity #biotech #healthspan #aging Beyond GLP-1: the next wave

Table 3 Results of a 52-week Monotherapy Trial in Adults with Type 2 Diabetes Mellitus a Figure 3 Mean HbA 1c for Adult Patients with Type 2 Diabetes Mellitus who Completed the 52-week Trial and for the Last Observation Carried Forward (LOCF, intent-to-treat) data at Week 52 (Monotherapy) Combination Therapy Add-on to Metformin In this 26-week trial, 1,091 adult patients with type 2 diabetes mellitus were randomized to liraglutide injection 0.6 mg, liraglutide injection 1.2 mg, liraglutide injection 1.8 mg, placebo, or glimepiride 4 mg (one-half of the maximal approved dose in the United States), all as add-on to metformin

Important caveat: the combination is not clinically validated

When traveling, keep the vial in original packaging with the pharmacy label visible

This determines the specific distribution pattern of vitamin C in the body

ACS Nano 4 (8), 45874594 (2010) Z

For example, mail-order pharmacy rules, step therapy requirements, or obscure formulary changes can derail an otherwise valid claim